182 related articles for article (PubMed ID: 10874883)
61. Expression of CD79a antigen in acute lymphoblastic leukaemias in children.
Nowicki M; Miśkowiak B; Konwerska A
Folia Histochem Cytobiol; 1999; 37(2):149-50. PubMed ID: 10353002
[No Abstract] [Full Text] [Related]
62. IgH DJ rearrangements within T-ALL correlate with cCD79a expression, an immature/TCRgammadelta phenotype and absence of IL7Ralpha/CD127 expression.
Asnafi V; Beldjord K; Garand R; Millien C; Bahloul M; LeTutour P; Douay L; Valensi F; Macintyre E
Leukemia; 2004 Dec; 18(12):1997-2001. PubMed ID: 15483677
[TBL] [Abstract][Full Text] [Related]
63. [Application of flow cytometry in the differential diagnosis of lymphoma/leukemia with aberrant antigen expression].
Xia CQ; Chen SL; Qi M; Xu XF
Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):532-5. PubMed ID: 15634450
[TBL] [Abstract][Full Text] [Related]
64. Phenotypic heterogeneity and aberrant markers expression in T-cell leukemia.
Babusíková O; Glasová M; Koníková E; Kusenda J; Cáp J; Gyárfás J; Koubek K
Neoplasma; 1998; 45(3):128-34. PubMed ID: 9717523
[TBL] [Abstract][Full Text] [Related]
65. Antigen Expression on Blast Cells and Hematological Parameters at Presentation in Acute Lymphoblastic Leukemia Patients.
Naeem S; Bukhari MH
J Coll Physicians Surg Pak; 2015 Jun; 25(6):407-11. PubMed ID: 26100991
[TBL] [Abstract][Full Text] [Related]
66. Differentiation of acute myeloid leukemia from B- and T-lineage acute lymphoid leukemias by real-time quantitative reverse transcription-PCR of lineage marker mRNAs.
Saussoy P; Vaerman JL; Straetmans N; Deneys V; Cornu G; Ferrant A; Latinne D
Clin Chem; 2004 Jul; 50(7):1165-73. PubMed ID: 15229149
[TBL] [Abstract][Full Text] [Related]
67. [Classification of acute leukemias by surface markers and correlation with the morphological diagnosis. Results of 111 cases].
von Fliedner V; Carrel S; Morell A; Heumann D; Losa G; Hirt A; Jeannet M; Mach JP; Cruchaud A
Schweiz Med Wochenschr; 1981 Oct; 111(41):1524-6. PubMed ID: 6975992
[TBL] [Abstract][Full Text] [Related]
68. Phenotypic and genetic characterization of adult T-cell acute lymphoblastic leukemia with del(9)(q34);SET-NUP214 rearrangement.
Chae H; Lim J; Kim M; Park J; Kim Y; Han K; Lee S; Min WS
Ann Hematol; 2012 Feb; 91(2):193-201. PubMed ID: 21720744
[TBL] [Abstract][Full Text] [Related]
69. Marker discrepancy as a diagnostic criterion for lymphoid neoplasms.
Sun T; Ngu M; Henshall J; Cuomo J; Eisenberg A; Benn P; Allen SL
Diagn Clin Immunol; 1988; 5(6):393-9. PubMed ID: 3265362
[TBL] [Abstract][Full Text] [Related]
70. A case of T-lineage lymphoblastic lymphoma/leukemia with t(4;11)(q21;p15) that switched to myelomonocytic leukemia at relapse.
Kawakami K; Miyanishi S; Amakawa R; Hayashi T; Kurata M; Nakamura F; Tanaka Y; Ohno Y; Shiku H
Int J Hematol; 1999 Apr; 69(3):196-9. PubMed ID: 10222659
[TBL] [Abstract][Full Text] [Related]
71. Immunophenotypic challenges in diagnosis of CD79a negativity in a patient with B acute lymphoblastic leukemia harboring intrachromosomal amplification of chromosome 21: a case report.
Berhili A; Bensalah M; ElMalki J; Elyagoubi A; Seddik R
J Med Case Rep; 2021 Oct; 15(1):531. PubMed ID: 34706776
[TBL] [Abstract][Full Text] [Related]
72. [Dynamic analysis of cell surface markers in acute leukemias unclassified with immunologic criteria].
Wang L; Zhang M; Song S
Zhonghua Nei Ke Za Zhi; 1996 Sep; 35(9):595-7. PubMed ID: 9592352
[TBL] [Abstract][Full Text] [Related]
73. Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia.
Pui CH; Rubnitz JE; Hancock ML; Downing JR; Raimondi SC; Rivera GK; Sandlund JT; Ribeiro RC; Head DR; Relling MV; Evans WE; Behm FG
J Clin Oncol; 1998 Dec; 16(12):3768-73. PubMed ID: 9850020
[TBL] [Abstract][Full Text] [Related]
74. Acute non-lymphocytic leukemia with expression of surface antigen CD7--morphological, cytochemical, immunological and ultrastructural features in eight patients.
Chopra HK; Nair CN; Barbhaya SA; Dhond SR; Badrinath Y; Kumar A; Zachariah LV; Advani SH
Indian J Cancer; 1993 Jun; 30(2):48-54. PubMed ID: 7693579
[TBL] [Abstract][Full Text] [Related]
75. Aberrant T-cell antigen expression in B lymphoblastic leukaemia.
Hussein S; Gill KZ; Sireci AN; Colovai AI; Small T; Emmons FN; Murty VV; Bhagat G; Alobeid B
Br J Haematol; 2011 Nov; 155(4):449-56. PubMed ID: 21923643
[TBL] [Abstract][Full Text] [Related]
76. Abnormal expansion of peripheral gamma delta T cells in patients with neurologic disorders.
Yamamoto T; Hara T; Nanba E; Ohashi S; Suzuki N; Yoshino K; Takeshita K
Brain Behav Immun; 1997 Sep; 11(3):157-66. PubMed ID: 9417802
[TBL] [Abstract][Full Text] [Related]
77. Chromosomal and immunophenotypic patterns in T cell acute lymphoblastic leukemia (T ALL) and lymphoblastic lymphoma (LBL).
Kaneko Y; Frizzera G; Shikano T; Kobayashi H; Maseki N; Sakurai M
Leukemia; 1989 Dec; 3(12):886-92. PubMed ID: 2586183
[TBL] [Abstract][Full Text] [Related]
78. An adult case of acute biphenotypic leukemia with characteristic mixed morphology.
Zucker ML; Plapp FV; Rachel JM; Murphy CA; Bohn BA; Boeschen JL; McCann LM; Peterson JT
Mo Med; 1993 Sep; 90(9):601-4. PubMed ID: 8232165
[TBL] [Abstract][Full Text] [Related]
79. Treatment of T-lineage acute lymphoblastic leukemia.
Amylon MD
Hematol Oncol Clin North Am; 1990 Oct; 4(5):937-49. PubMed ID: 2262486
[TBL] [Abstract][Full Text] [Related]
80. Cell surface markers in acute lymphoblastic leukemia.
Humphrey GB; Blackstock R; Filler J
Ann Clin Lab Sci; 1980; 10(3):169-80. PubMed ID: 6967278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
